Fluorescent RNA Aptamers as a Tool to Study RNA-Modifying Enzymes.

RNA-modifying enzymes are difficult to assay due to the absence of fluorometric substrates. Here we show that the Broccoli, a previously reported fluorescent RNA-dye complex, can be modified to contain N(6)-methyladenosine, a prevalent mRNA base modification. Methylated Broccoli is nonfluorescent but, upon demethylation by the RNA demethylases fat mass and obesity-associated protein (FTO) or ALKBH5, it binds and activates the fluorescence of its cognate fluorophore. We describe a high-throughput screen (HTS) for FTO inhibitors using the fluorogenic methylated Broccoli substrate HTS assay, which performs robustly with a Z' factor >0.8 in the LOPAC1280 library. This allowed the identification of novel high-affinity FTO inhibitors. Several of these compounds were selective for FTO over the related demethylase, ALKBH5, and increase methylation of endogenous FTO target mRNAs in cells. Lastly, we show that Broccoli can be modified to contain other base modifications, suggesting that this approach could be generally applicable for assaying diverse RNA-modifying enzymes.

[1]  P. Trackman,et al.  A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. , 2002, Analytical biochemistry.

[2]  Grigory S. Filonov,et al.  Broccoli: Rapid Selection of an RNA Mimic of Green Fluorescent Protein by Fluorescence-Based Selection and Directed Evolution , 2014, Journal of the American Chemical Society.

[3]  Christopher E. Mason,et al.  Single-nucleotide resolution mapping of m6A and m6Am throughout the transcriptome , 2015, Nature Methods.

[4]  Vicki J. Barwick,et al.  Sources of uncertainty in gas chromatography and high-performance liquid chromatography , 1999 .

[5]  Chengqi Yi,et al.  N6-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO , 2011, Nature chemical biology.

[6]  M. Mann,et al.  Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. , 2014, Cell reports.

[7]  Douglas S. Auld,et al.  Considerations for the design and reporting of enzyme assays in high-throughput screening applications , 2014 .

[8]  Samie R Jaffrey,et al.  An expanding universe of mRNA modifications , 2014, Nature Structural &Molecular Biology.

[9]  S. Brunak,et al.  Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis , 2010, Science Signaling.

[10]  A. Ferré-D’Amaré,et al.  Structural basis for activity of highly efficient RNA mimics of green fluorescent protein , 2014, Nature Structural &Molecular Biology.

[11]  P. Herdewijn,et al.  Hybridization properties of base-modified oligonucleotides within the double and triple helix motif , 1998 .

[12]  Wenjiao Song,et al.  Fluorescence Imaging of Cellular Metabolites with RNA , 2012, Science.

[13]  Sheng Li,et al.  The pivotal regulatory landscape of RNA modifications. , 2014, Annual review of genomics and human genetics.

[14]  Michael A McDonough,et al.  Structural basis for inhibition of the fat mass and obesity associated protein (FTO). , 2013, Journal of medicinal chemistry.

[15]  Cheng Luo,et al.  Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. , 2012, Journal of the American Chemical Society.

[16]  S. Jaffrey,et al.  RNA Mimics of Green Fluorescent Protein , 2011, Science.

[17]  P. Limbach,et al.  Summary: the modified nucleosides of RNA. , 1994, Nucleic acids research.

[18]  J. Piccirilli,et al.  A G-Quadruplex-Containing RNA Activates Fluorescence in a GFP-Like Fluorophore , 2014, Nature chemical biology.

[19]  J. Weidner,et al.  Basics of Enzymatic Assays for HTS , 2012 .

[20]  T. Okabe,et al.  High-throughput screening with quantitation of ATP consumption: a universal non-radioisotope, homogeneous assay for protein kinase. , 2004, Assay and drug development technologies.

[21]  Sean Ekins,et al.  Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery. , 2009, Drug discovery today.

[22]  Arthur Christopoulos,et al.  International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology , 2003, Pharmacological Reviews.

[23]  Cheng Luo,et al.  Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5 , 2014, Nucleic acids research.

[24]  J. Kowalak,et al.  A novel method for the determination of post-transcriptional modification in RNA by mass spectrometry. , 1993, Nucleic acids research.

[25]  D. Burk,et al.  The Determination of Enzyme Dissociation Constants , 1934 .

[26]  Y. Ohya,et al.  Mitochondria-specific RNA-modifying Enzymes Responsible for the Biosynthesis of the Wobble Base in Mitochondrial tRNAs , 2005, Journal of Biological Chemistry.

[27]  John S Lazo,et al.  Building a Pharmacological Lexicon: Small Molecule Discovery in Academia , 2007, Molecular Pharmacology.

[28]  A. Isaksson,et al.  Screening of an annotated compound library for drug activity in a resistant myeloma cell line , 2006, Cancer Chemotherapy and Pharmacology.

[29]  Samie R. Jaffrey,et al.  Plug-and-Play Fluorophores Extend the Spectral Properties of Spinach , 2014, Journal of the American Chemical Society.

[30]  F. Ashcroft,et al.  FTO influences adipogenesis by regulating mitotic clonal expansion , 2015, Nature Communications.

[31]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[32]  D. McGuinness,et al.  m 6 a RNA Methylation: The Implications for Health and Disease , 2014 .

[33]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[34]  Samie R. Jaffrey,et al.  RNA mimics of green fluorescent protein , 2013 .

[35]  O. Elemento,et al.  Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons , 2012, Cell.

[36]  Lars Juhl Jensen,et al.  A Comparison of Protein Kinases Inhibitor Screening Methods Using Both Enzymatic Activity and Binding Affinity Determination , 2014, PloS one.

[37]  D. Stresser,et al.  Design and application of fluorometric assays for human cytochrome P450 inhibition. , 2002, Methods in enzymology.

[38]  Simon Hess,et al.  The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry , 2013, Nature Neuroscience.